Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

ciaa1361.pdf (166.86 KB)

Document type

Article

Version

Published version

Publication date

2020-09-10

Publication license

cc by-nc-nd (c) Ingen, Jakko van et al, 2020
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/181039

Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1093/cid/ciaa1361

Abstract

Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions.

Subject

Malalties del pulmó, Antibiòtics

Subject (English)

Pulmonary diseases, Antibiotics

Citation

Collections

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citation

INGEN, Jakko van, et al. Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey. Clinical Infectious Diseases. 2020. ISSN 1537-6591. [consulted: 18 of August of 2026]. Available at: https://hdl.handle.net/2445/181039

Export metadata

JSON - METS

Share record